CAS: 13838-16-9; Enflurane

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号428-96-6 2-chloro-1-(dic...

合成工艺路线路线简述

    2-氯-1-(二氯甲氧基)-1,1,2-三氟乙烷置于氢氟酸,氯化锑(V)体系中,化学反应生成恩氟烷
    参考文献:全身麻醉剂.3.氟化甲基乙基醚作为麻醉剂.
    标题:全身麻醉剂.3.氟化甲基乙基醚作为麻醉剂.
    摘要:
    Doi:10.1021/jm00276A008

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-2007172520-A1
    优先权日:2005-11-18
    标题:Immunotargeting of Nonionic Surfactant Vesicles
    发明人:VANAUKER MICHAEL; PLAAS ANNA; HOOD ELIZABETH
    权利人:UNIV SOUTH FLORIDA
    摘要:An immunoniosmes for targeted delivery of therapeutic agents to specific tissues in a host and methods of synthesis of those niosomes. An antibody molecule having specificity for a target antigen, such as a cell surface marker or other marker differentially expressed on a target cell, is covalently coupled to a functionalized membrane constituent. In a particular embodiment the functionalized membrane constituent is polyoxyethylene sorbitan monostearate functionalized with cyanuric chloride. The niosomes of this invention thus provide a composition that enhances internalization or retention of the bioactive agent of the niosome into the cytoplasm of the cells of the target tissue by providing a high degree of target specificity. Furthermore, the membrane vesicle enhances the life of the therapeutic agent by preventing its degradation in the extracellular environment, while exhibiting lower toxicity than can occur with some liposomes. The niosomes of the present invention are thus particularly useful as vehicles for the delivery of therapeutics to specific target cells.

    专利号:US-2024400552-A1
    优先权日:2016-11-11
    标题 :Heterocyclic modulators of lipid synthesis
    发明人:BUCKLEY DOUGLAS I; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
    权利人:SAGIMET BIOSCIENCES INC
    摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by dysregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

    专利号:US-11622968-B2
    优先权日:2011-03-08
    标 题:Heterocyclic modulators of lipid synthesis
    发明人:BUCKLEY DOUGLAS; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
    权利人:SAGIMET BIOSCIENCES INC
    摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

    专利号:US-2015352230-A1
    优先权日:2013-01-11
    标 题:Synthesis and isolation of dendrimer based imaging systems
    发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
    权利人:UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

    专利号:US-7605291-B2
    优先权日:2006-04-27
    标 题 :Method for the preparation of volatile Anesthetics
    发明人:MALDONADO ADALBERTO
    权利人:MALDONADO ADALBERTO
    摘要:The present invention is concerned with the automated control of the synthesis and purification of components useful in the synthesis and purification of volatile anesthetics. The invention is particularly useful in its application to the purification of acetone used in the purification of isoflurane.
    上海氟德化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fwdchem.com.cn
    企业联系电话:021-54450828,13501997194👤
    📞上海氟德化工有限公司 ⚠️参考联系方式
    联系人:周先生
    电话:021-54450828,13501997194
    手机:13501997194
    传真:021-54450901
    邮箱:sales@fwdchem.com
    通信地址: 上海市徐汇区田州路159号15单元莲花大厦802室
    邮编: 200233
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市徐汇区田州路159号15单元莲花大厦802室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Andrade LA, Silla JM, Stephens SL, Marat K, da Cunha EF, Ramalho TC, van Wijngaarden J, Freitas MP. Conformational Exploration of Enflurane in Solution and in a Biological Environment. J Phys Chem A. 2015 Oct 29;119(43):10735-42. doi: 10.1021/acs.jpca.5b08087. Epub 2015 Oct 19. doi: 10.1007/s10072-013-1474-x. Epub 2013 Aug 11. doi: 10.1007/s12630-013-0091-8. Epub 2013 Dec 7. doi: 10.1021/jp205081r. Epub 2011 Sep 13. doi: 10.1002/chem.201601201. Epub 2016 Jun 3. doi: 10.1016/S0034-7094(11)70069-1. English, Portuguese, Spanish. Erratum in: Rev Bras Anestesiol. 2011 Nov-Dec;61(6):832. Retraction in: Middle East J Anaesthesiol. 2012 Feb;21(4):659. eCollection 2014.
    9: Murakami M, Niwa H, Kushikata T, Watanabe H, Hirota K, Ono K, Ohba T. Inhalation anesthesia is preferable for recording rat cardiac function using an electrocardiogram. Biol Pharm Bull. 2014;37(5):834-9. doi: 10.1039/c3cp50385b. Epub 2013 Mar 15. doi: 10.1039/c0cp02085k. Epub 2011 Feb 3. doi: 10.1007/s00894-012-1678-7. Epub 2012 Dec 5.
    13: Wang X, Zhang XF. Enflurane requirement for blocking adrenergic responses to incision in infants and children. World J Pediatr. 2008 Feb;4(1):49-52. doi: 10.1007/s12519-008-0010-1.

    合成参考文献


    摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 12(668), 1981
    摘要:Malan TP et al; Anesth Analg 77 (4): 817-21 (1993)
    摘要:Yalkowsky SH, Dannenfelser RM; The AQUASOL dATAbASE of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy (1992)
    摘要:Franke C et al; Chemosphere 29: 1501-14 (1994)
    摘要:Orhan H et al; Anesthesiology 95 (1): 165-75 (2001)
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知